NICE backs broad use for Gilead/Galapagos arthritis pill Jys...

Patients with rheumatoid arthritis (RA) in England will be able to get treatment with Gilead Sciences and Galapagos’ JAK inhibitor Jyseleca, after it was backed by cost-effectiveness agency

Gilead's rheumatoid arthritis pill approved in Japan

Gilead has scored a major approval for its troubled rheumatoid arthritis pill filgotinib, after regulators in Japan granted it a licence following an FDA rejection in August.

Gilead and Galapagos shares hit as filgotinib disappoints

Gilead and Galapagos' late-stage trial of their ulcerative colitis drug filgotinib has hit its target – but shares in both companies were down after data suggested the drug may struggle for

Gilead says arthritis drug filgotinib fails in follow-up use...